PHF21A expression as a biomarker of hepatocellular carcinoma progression and prognosis.

Huang, Jia-Qing; Ji, Li-Chen; Jing, Qiang-An; He, Yi-Chen; Ma, Ying-Yu; Tong, Xiang-Min

Huang, Jia-Qing; Ji, Li-Chen; Jing, Qiang-An; He, Yi-Chen; Ma, Ying-Yu; Tong, Xiang-Min.

Afiliação

Huang JQ; The Second Clinic Medical College, Zhejiang Chinese Medicine University, Hangzhou, Zhejiang, China.
Ji LC; Laboratory Medicine Center, Department of Laboratory Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Jing QA; Laboratory Medicine Center, Department of Laboratory Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
He YC; Department of Orthopedics, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.
Ma YY; Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Tong XM; Laboratory Medicine Center, Department of Laboratory Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.

Neoplasma ; 69(6): 1349-1358, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36305691

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/genética; Neoplasias Hepáticas/genética; Prognóstico; Biomarcadores; Estimativa de Kaplan-Meier; Biomarcadores Tumorais/metabolismo; Histona Desacetilases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Neoplasma Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google